ArticleHealth affairs scholar2026
The financial implications of selective disenrollment from Medicare advantage.
Article in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Prior studies show that beneficiaries with relatively high health needs are more likely to disenroll from Medicare Advantage (MA) and return to Traditional Medicare (TM). However, the financial implications for MA plans of selective disenrollment have not been quantified. Methods: We calculated annual disenrollment rates from MA to TM, and compared TM spending in months 1-12 and 13-24 following disenrollment with the expected capitation payments that MA plans would have received. Results: For 2019 disenrollees, TM spending in the first 12 months following disenrollment averaged 30% higher than the expected MA capitation. However, disenrollment was relatively rare-1.7% of MA members in 2019, much lower than the 4.3% in 2007, and declining further to 1.2% in 2022. Because disenrollment is rare, its effect on plan finances is limited, increasing spending on MA by approximately 0.6%. Conclusion: Although the effect of selective disenrollment on plan finances is limited, the consistent direction and magnitude of selection suggest that a measured policy response is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.